TELO Stock Analysis: Buy, Sell, or Hold?
TELO - Telomir Pharmaceuticals, Inc. Common Stock
$1.14
-0.08 (-6.56%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 03, 2026
2d
Get Alerted When TELO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TELO is down 14.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TELO is down 14.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TELO is currently trading at $1.14, which is considered oversold relative to its 30-day fair value range of $1.28 to $1.43.
Technical Outlook: Technically, TELO is in a downtrend. The price is currently testing key support at $1.11. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.50 (+1170.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TELO is in a downtrend. The price is currently testing key support at $1.11. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.50 (+1170.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.28 -
$1.43
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding TELO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.6%)
- BULLISH: Trading 1170.5% below Wall St target ($15.50)
- WARNING: Recommendation downgraded due to -14.9% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.28 -
$1.43
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.11
Resistance Level
$1.41
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.36
Wall Street Target
$15.50
(+1170.5%)
Last updated: January 31, 2026 4:00 AM ET
Data refreshes hourly during market hours. Next update: 5:00 AM
Data refreshes hourly during market hours. Next update: 5:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TELO showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
Advanced TELO Option Strategies
Professional options setups generated by AI based on today's TELO price and gamma walls.
